Prevalence of thyroid dysfunction among Iranian older adults: a cross-sectional study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 Dec 2023
08 Dec 2023
Historique:
received:
10
09
2023
accepted:
04
12
2023
medline:
9
12
2023
pubmed:
9
12
2023
entrez:
8
12
2023
Statut:
epublish
Résumé
There is limited data on the prevalence of thyroid dysfunction in the older population. This study aimed to determine the prevalence of thyroid dysfunction among a sample of Iranian older adults. A cross-sectional analysis of older adults who aged 60 years and over was conducted. A total of 363 subjects were randomly selected from Birjand longitudinal aging study (BLAS) cohort study. Serum thyroid-stimulating hormone (TSH) level, total thyroxine (T4) and total triiodothyronine (T3) were measured by the enzyme-linked immunosorbent assay (ELISA). Based on thyroid function tests and history of taking medicines used to treat thyroid disorders, participants were classified into the following groups: euthyroid, overt/subclinical hypothyroidism, and overt/subclinical hyperthyroidism. Subsequently, the crude and World Health Organization (WHO) age-standardized prevalence were estimated for different thyroid function categories. A total of 171 men and 192 women, aged 60-94 years, were randomly selected. The crude prevalence of total hypothyroidism was 22.31% (subclinical [18.46%], overt [3.86%]), and that of hyperthyroidism was 1.66% (subclinical [1.38%], overt [0.28%]). The crude prevalence of total thyroid dysfunction was, therefore, 23.97%. A female preponderance was noticed in both total (P-value = 0.035) and overt (P-value = 0.035) hypothyroidism. An increasing trend with age was noticed in the prevalence of total hypothyroidism (P-value = 0.049). Age-standardized prevalence of total hypothyroidism and hyperthyroidism was 26.63% (95% confidence interval [CI] 20.58-33.69%) and 1.11% (95% CI 0.49-2.51%), respectively. A considerable proportion of our study population demonstrated evidence of thyroid dysfunction, particularly subclinical hypothyroidism. Our findings highlight the importance of further investigation of thyroid disorders among older Iranian adults.
Identifiants
pubmed: 38066216
doi: 10.1038/s41598-023-49085-2
pii: 10.1038/s41598-023-49085-2
pmc: PMC10709612
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21651Informations de copyright
© 2023. The Author(s).
Références
Aging Med (Milton). 2021 Jul 02;4(2):70-92
pubmed: 34250426
Int J Endocrinol Metab. 2017 Oct 28;15(4):e57758
pubmed: 29696034
Thyroid. 2002 Oct;12(10):839-47
pubmed: 12487765
J Diabetes Metab Disord. 2020 Mar 05;19(1):551-559
pubmed: 32550207
East Mediterr Health J. 2021 Feb 25;27(2):151-158
pubmed: 33665799
Gerontology. 2019;65(1):1-8
pubmed: 30032140
Nat Rev Endocrinol. 2018 May;14(5):301-316
pubmed: 29569622
Thyroid. 2012 Dec;22(12):1200-35
pubmed: 22954017
Best Pract Res Clin Endocrinol Metab. 2010 Feb;24(1):13-27
pubmed: 20172467
J Gerontol A Biol Sci Med Sci. 2011 Jul;66(7):809-14
pubmed: 21628677
Eur Thyroid J. 2019 Jun;8(3):130-143
pubmed: 31259155
Ann Intern Med. 2006 Oct 17;145(8):573-81
pubmed: 17043339
Lancet Diabetes Endocrinol. 2018 Sep;6(9):733-742
pubmed: 30017801
Arch Intern Med. 2012 May 28;172(10):811-7
pubmed: 22529180
Thyroid. 2020 Apr;30(4):568-579
pubmed: 32075540
Am J Clin Nutr. 1969 Dec;22(12):1584-8
pubmed: 5362485
J Endocrinol Invest. 2017 Sep;40(9):945-952
pubmed: 28343318
Intern Med J. 2007 Jul;37(7):448-55
pubmed: 17547723
PLoS Med. 2020 Jun 8;17(6):e1003138
pubmed: 32511229
Thyroid. 2018 May;28(5):566-574
pubmed: 29631518
Arch Intern Med. 2000 Feb 28;160(4):526-34
pubmed: 10695693
J Am Geriatr Soc. 2015 Aug;63(8):1663-73
pubmed: 26200184
Eur J Endocrinol. 2006 Aug;155(2):219-28
pubmed: 16868134
Arch Intern Med. 2009 Nov 23;169(21):2011-7
pubmed: 19933964
J Endocrinol Invest. 2008 May;31(5):422-31
pubmed: 18560260
Eur J Endocrinol. 2013 Oct 01;169(5):613-20
pubmed: 23975540
J Clin Endocrinol Metab. 2014 Mar;99(3):923-31
pubmed: 24423323
Sci Rep. 2019 Sep 11;9(1):13156
pubmed: 31511587
Cad Saude Publica. 2011 Jan;27(1):155-61
pubmed: 21340114
Iran J Public Health. 2020 Feb;49(2):377-385
pubmed: 32461946
Biomed Pharmacother. 2022 Feb;146:112613
pubmed: 35062076
N Engl J Med. 2017 Jun 29;376(26):2556-2565
pubmed: 28657873
Sci Rep. 2016 Dec 14;6:38912
pubmed: 27966590
J Clin Endocrinol Metab. 2002 Feb;87(2):489-99
pubmed: 11836274
JAMA. 2004 Dec 1;292(21):2591-9
pubmed: 15572717